Lexicon Pharmaceuticals (LXRX) Change in Acquisitions & Divestments (2023 - 2025)
Lexicon Pharmaceuticals (LXRX) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $27.0 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments fell 66.25% to $27.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $252.9 million through Dec 2025, down 19.57% year-over-year, with the annual reading at $252.9 million for FY2025, 19.57% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $27.0 million at Lexicon Pharmaceuticals, down from $78.8 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $105.6 million in Q1 2025, with the low at $27.0 million in Q4 2025.
- Average Change in Acquisitions & Divestments over 3 years is $61.8 million, with a median of $58.5 million recorded in 2023.
- The sharpest move saw Change in Acquisitions & Divestments soared 192.12% in 2024, then tumbled 66.25% in 2025.
- Over 3 years, Change in Acquisitions & Divestments stood at $52.0 million in 2023, then skyrocketed by 53.85% to $80.0 million in 2024, then crashed by 66.25% to $27.0 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $27.0 million, $78.8 million, and $41.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.